Federal Register: FDA Replaces 2024 Draft Guidance to Update Testing, Performance Frameworks for Combination Drug Delivery Devices
October 31, 2026
October 31, 2026
WASHINGTON, Oct. 31 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
Essential Drug Delivery Performance Characteristics for Devices Intended To Deliver Drugs and Biological Products; Revised Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA) is announcing the availability of a revised draft guidance for industry entitled "Es . . .
* * *
Essential Drug Delivery Performance Characteristics for Devices Intended To Deliver Drugs and Biological Products; Revised Draft Guidance for Industry; Availability
The Food and Drug Administration (FDA) is announcing the availability of a revised draft guidance for industry entitled "Es . . .